Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fundico is a specialized financial technology platform designed to bridge the funding gap for clinical-stage biotechnology and pharmaceutical companies. The company provides a marketplace that allows institutional and accredited investors to provide direct funding for specific clinical trials in exchange for a share of future royalties or milestone payments. By decoupling the funding of individual trials from overall corporate equity, Fundico aims to accelerate drug development and provide biotech firms with non-dilutive capital. The platform focuses on high-potential therapeutic programs, particularly in oncology and rare diseases, where traditional venture capital or public market funding may be insufficient.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fundico.